The Vladimir Region and Veropharm (Abbott group) signed a memorandum of cooperation at the St. Petersburg International Economic Forum, the regional administration reports.
In 2019, Veropharm plans to put into operation two new lines for the production of hospital-profile medicines, as well as to bring to full capacity the line for the production of Xylene nasal drops at the plant in the Vladimir Region. This was reported on the website of the Administration of the Vladimir Region upon the meeting of the company’s management with Vladimir Sipyagin, Governor of the Region.
Management of Vladimir bread combine started development of the mutual project relate to confectionary production with manufacturers from Croatia and Slovenia. As expected the products will be sold at Russian and European market, as was reported by Tass, Aleksey Lyalin, manager of the bread factory.
“We have signed a contract with Oxford Immunotec, a leading global immunodiagnostics company from the UK. Our basic and first joint project with the British is the collaboration on the brand called T-Spot. This is a sophisticated technology protected by a patent, which we localize in the territory of the Russian Federation,” Dmitry Kudlay, Director General of Generium, told Vademecum. “Our cooperation will significantly reduce the cost of the test system.”
Vladimir bread factory management started developing a confectionery co-production project with Croatian and Slovenian companies. The products are expected to be sold in Russia and Europe, as reported by Aleksey Lyalin, Vladimir bread factory manager.
Russian-Dutch company De Heus will build a plant for the production of fish feed-stuff in the Vladimir Region by 2019. The total investments into the project is estimated at 2 billion rubles, as Company’s Director General Alexander Matveev told TASS on Tuesday.